Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
Clinical trial NCT03680326 · COMPLETED
Trial details
- NCT number
- NCT03680326
- Sponsor
- Hospital Hietzing
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-02
- Primary completion
- 2018-03-22
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.